cuIoabEHVdIHWlRmdM
名前:Hipolito日付:2014/12/27 00:40:45
A law firm biology report samples Lilly's compound, known as Amyvid, has already been approved by the U.S. Food and Drug Administration, but Medicare reimbursement is seen as critical for the company because most people begin showing signs of dementia around age 65, the age when Medicare coverage kicks in.